BioCentury
ARTICLE | Clinical News

Impracor update

October 15, 2012 7:00 AM UTC

Imprimis began a pharmacokinetic trial to compare Impracor vs. an oral dose of ketoprofen in 40 healthy volunteers. The compound has completed a Phase III trial to treat pain associated with mild to m...